Hospital health care cost of diarrheal disease in Northern Ghana

Journal of Infectious Diseases

Volumn 202, Issue SUPPL. 1, 2010, Pages

  Aikins, Moses ^a   Armah, George ^b   Akazili, James ^c   Hodgson, Abraham ^c  

^a School of Public Health   (United States)

^b University of Ghana   (Ghana)

^c MINISTRY OF HEALTH   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; DIARRHEA; FEMALE; GHANA; HOSPITAL COST; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; REHYDRATION; ROTAVIRUS INFECTION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; DIARRHEA; FEMALE; GHANA; HOSPITAL COSTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; REHYDRATION SOLUTIONS; ROTAVIRUS INFECTIONS;

EID: 77955685405     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653573     Document Type: Article

References (29)

1. Bern C. Martines, J, de Zoysa I, Glass, R. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull World Health Organ 1992; 70:705-714.
2. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12(2):304-306.
3. Kiulia NM, Kamenwa R, Irimu G, et al. The epidemiology of human rotavirus associated with diarrhoea in Kenyan children: a review. J Trop Pediatr 2008; 54(6):401-405.
4. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-972.
5. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361:2226-2234.
6. Hori H, Akpedonu P, Armah G, et al. Enteric pathogens in severe forms of acute gastroenteritis in Ghanaian children. Acta Paediatr Jpn 1996; 38:672-676.
7. Asmah RH, Green J, Armah GE, et al. Rotavirus G and P genotypes in rural Ghana. J Clin Microbiol 2001; 39:1981-1984.
8. Binka FN, Anto FK, Oduro AR, et al. Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health 2003; 8:840-846.
9. Armah GE, Mingle JA, Dodoo AK, et al. Seasonality of rotavirus infection in Ghana. Ann Trop Paediatr 1994; 14:223-229.
10. Lorgelly, PK, Joshi D, Iturriza Gómara M, et al. Infantile gastroenteritis in the community: a cost-of-illness study. Epidemiol Infect 2008; 136: 34-43.
11. Lee BP, Azimi PH, Staat MA, et al. Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J 2005; 24:984-988.
12. Luquero Alcalde FJ, Eiros Bouza JM, Rubio AP, Bachiller Luque MR, Castrodeza Sanz JJ, Ortiz de Lejarazu LR. Gastroenteritis by rotavirus in Spanish children. analysis of the disease burden. Eur J Pediatr 2008; 167:549-555.
13. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005; 192:1720-1726.
14. Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M;REVEAL Study Group. Cost of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL study. J Infect Dis 2007; 195(Suppl 1):S36-S44.
15. Standaert B, Harlin O, Desselberger U. The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J 2008; 27(Suppl):S20-S27.
16. Mendelsohn AS, Asirvatham JR, Mwamburi DM, et al. Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India. Trop Med Int Health 2008; 13(7):934-942.
17. Lorgelly PK, Joshi D, Iturriza Gómara M, Gray J, MugfordM. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteristis in the United Kingdom. Epidemiol Infect 2008; 136: 45-55.
18. Constenla DO, Linhares AC, Rheingas RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr 2008; 26(4):388-396.
19. RotaTeq summary of product characteristics. Lyon, France: Sanofi Pasteur, 2006.
20. Rotarix summary of product characteristics. Ontario, Canada: GlaxoSmith Kline, 2006.
21. World Health Organization. Guidelines for estimating the economic burden of diarrhoeal disease with focus on assessing the impact of rotavirus diarrhoea. 2005. http://www.who.int/vaccines-documents/ DocsPDF05/IVB05-10.pdf. Accessed 1 January 2009.
22. Bank of Ghana. Interbank transactions exchange rate [2003]. Accra, Ghana: Research Department, Bank of Ghana, 2003.
23. Bank of Ghana. Interbank transactions exchange rate [2004]. Accra, Ghana: Research Department, Bank of Ghana, 2004.
24. WHO-CHOICE. Recults of unit costs for patient services for the 14 GDB regions. http://www.who.int/choice/costs/unit-regions/en/index html.
25. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81:197-204.
26. Ferrccio C, Prado V, Ojeda A, et al. Epidemiologic patterns of acute diarrhoea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol 1991; 134:614-627.
27. Phillips MA. Why do costings? Health Policy Planning 1987; 2(3): 255-257.
28. Goossens LMA, Standaert B, Hartwig N, et al. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine 2008; 26:1118-1127.
29. Ho AM, Nelson EA, Walker DG. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective. Arch Dis Child 2008; 93:52-58.